Rab7 and the CMT2B disease.

Area of Science:

• Neuroscience
• Genetics
• Cell Biology

Background:

• Charcot-Marie-Tooth type 2B (CMT2B) is an autosomal dominant axonal neuropathy characterized by sensory loss, muscle weakness, and foot ulcers.
• Four missense mutations in the rab7 gene have been identified as the cause of CMT2B.
• Rab7, a small G-protein, regulates vesicular transport in the endocytic pathway.

Purpose of the Study:

• To review the molecular mechanisms underlying Charcot-Marie-Tooth type 2B.
• To elucidate how rab7 gene mutations lead to axonal pathology in peripheral neurons.

Main Methods:

• Review of existing literature on CMT2B and rab7 gene mutations.
• Analysis of the functional consequences of CMT2B-associated Rab7 mutations in human cells.
• Discussion of Rab7's role in vesicular transport and endocytic pathways.

Main Results:

• CMT2B-associated Rab7 mutations result in altered nucleotide dissociation rates and impaired GTPase activity.
• Mutant Rab7 proteins are predominantly GTP-bound and can rescue Rab7 function in depleted cells, indicating they are activated forms.
• These activated Rab7 forms are implicated in the pathogenesis of CMT2B.

Conclusions:

• The identified mutations generate constitutively active Rab7 proteins, contributing to CMT2B development.
• Despite understanding Rab7's role, the specific mechanisms by which these mutations affect peripheral neurons remain unclear.
• Further research is needed to fully understand the molecular basis of CMT2B and its axonal pathology.